Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20737Active, not recruiting
Trial of tapentadol, morphine and Placebo-COD Research Private Ltd in Neuralgia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Pain modulation, Diffuse noxious inhibitory control and 1 more. Started Jul 2011; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20737.